Mabwell Announces Updated Board Composition and Committee Appointments

Bulletin Express06-18

Mabwell (Shanghai) Bioscience Co., Ltd. released an updated roster of its Board of Directors and committee assignments, effective 18 June 2026.

The Board now comprises nine directors: • Executive Directors (5): Mr. Tang Chunshan; Dr. Liu Datao (serving as Chairman); Dr. Wu Hai; Mr. Hua Jun; and Dr. Gui Xun. • Independent Non-Executive Directors (4): Mr. Qin Zhengyu; Mr. Zhou Rui; Ms. Li Fan; and Ms. Wang Fang.

Committee structure and leadership: 1. Audit Committee – chaired by Independent Non-Executive Director Mr. Qin Zhengyu, with membership including Mr. Zhou Rui and Ms. Li Fan. 2. Remuneration and Appraisal Committee – chaired by Ms. Li Fan; members are Dr. Liu Datao and Mr. Zhou Rui. 3. Nomination Committee – chaired by Mr. Zhou Rui; members include Mr. Tang Chunshan and Ms. Li Fan. 4. Strategy Committee – chaired by Dr. Liu Datao, with Dr. Wu Hai and Mr. Hua Jun as members. 5. ESG Committee – chaired by Dr. Liu Datao, with Ms. Li Fan as a member.

The disclosure underscores Mabwell’s governance framework, highlighting a balanced mix of executive insight and independent oversight across its five specialized committees.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1149771039?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-18 22:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149771039","market":"us","top_or_hot":-1,"title":"Mabwell Announces Updated Board Composition and Committee Appointments","media":"Bulletin Express","content":"<p>Mabwell (Shanghai) Bioscience Co., Ltd. released an updated roster of its Board of Directors and committee assignments, effective 18 June 2026.</p>\n<p>The Board now comprises nine directors:\n• Executive Directors (5): Mr. Tang Chunshan; Dr. Liu Datao (serving as Chairman); Dr. Wu Hai; Mr. Hua Jun; and Dr. Gui Xun.  \n• Independent Non-Executive Directors (4): Mr. Qin Zhengyu; Mr. Zhou Rui; Ms. Li Fan; and Ms. Wang Fang.</p>\n<p>Committee structure and leadership:\n1. Audit Committee – chaired by Independent Non-Executive Director Mr. Qin Zhengyu, with membership including Mr. Zhou Rui and Ms. Li Fan.  \n2. Remuneration and Appraisal Committee – chaired by Ms. Li Fan; members are Dr. Liu Datao and Mr. Zhou Rui.  \n3. Nomination Committee – chaired by Mr. Zhou Rui; members include Mr. Tang Chunshan and Ms. Li Fan.  \n4. Strategy Committee – chaired by Dr. Liu Datao, with Dr. Wu Hai and Mr. Hua Jun as members.  \n5. ESG Committee – chaired by Dr. Liu Datao, with Ms. Li Fan as a member.</p>\n<p>The disclosure underscores Mabwell’s governance framework, highlighting a balanced mix of executive insight and independent oversight across its five specialized committees.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mabwell Announces Updated Board Composition and Committee Appointments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMabwell Announces Updated Board Composition and Committee Appointments\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-18 22:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Mabwell (Shanghai) Bioscience Co., Ltd. released an updated roster of its Board of Directors and committee assignments, effective 18 June 2026.</p>\n<p>The Board now comprises nine directors:\n• Executive Directors (5): Mr. Tang Chunshan; Dr. Liu Datao (serving as Chairman); Dr. Wu Hai; Mr. Hua Jun; and Dr. Gui Xun.  \n• Independent Non-Executive Directors (4): Mr. Qin Zhengyu; Mr. Zhou Rui; Ms. Li Fan; and Ms. Wang Fang.</p>\n<p>Committee structure and leadership:\n1. Audit Committee – chaired by Independent Non-Executive Director Mr. Qin Zhengyu, with membership including Mr. Zhou Rui and Ms. Li Fan.  \n2. Remuneration and Appraisal Committee – chaired by Ms. Li Fan; members are Dr. Liu Datao and Mr. Zhou Rui.  \n3. Nomination Committee – chaired by Mr. Zhou Rui; members include Mr. Tang Chunshan and Ms. Li Fan.  \n4. Strategy Committee – chaired by Dr. Liu Datao, with Dr. Wu Hai and Mr. Hua Jun as members.  \n5. ESG Committee – chaired by Dr. Liu Datao, with Ms. Li Fan as a member.</p>\n<p>The disclosure underscores Mabwell’s governance framework, highlighting a balanced mix of executive insight and independent oversight across its five specialized committees.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02493","symbol_name":"迈威生物-B","start_time":0,"source_url":"","article_id":"1149771039","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149771039","pubTimestamp":1781791499,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Mabwell (Shanghai) Bioscience Co., Ltd. released an updated roster of its Board of Directors and committee assignments, effective 18 June 2026. The Board now comprises nine directors: • Executive...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02493":"迈威生物-B"},"translate_title":"Mabwell宣布更新的董事会组成和委员会任命","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02493":1},"content_text":"Mabwell (Shanghai) Bioscience Co., Ltd. released an updated roster of its Board of Directors and committee assignments, effective 18 June 2026.\nThe Board now comprises nine directors:\n• Executive Directors (5): Mr. Tang Chunshan; Dr. Liu Datao (serving as Chairman); Dr. Wu Hai; Mr. Hua Jun; and Dr. Gui Xun.  \n• Independent Non-Executive Directors (4): Mr. Qin Zhengyu; Mr. Zhou Rui; Ms. Li Fan; and Ms. Wang Fang.\nCommittee structure and leadership:\n1. Audit Committee – chaired by Independent Non-Executive Director Mr. Qin Zhengyu, with membership including Mr. Zhou Rui and Ms. Li Fan.  \n2. Remuneration and Appraisal Committee – chaired by Ms. Li Fan; members are Dr. Liu Datao and Mr. Zhou Rui.  \n3. Nomination Committee – chaired by Mr. Zhou Rui; members include Mr. Tang Chunshan and Ms. Li Fan.  \n4. Strategy Committee – chaired by Dr. Liu Datao, with Dr. Wu Hai and Mr. Hua Jun as members.  \n5. ESG Committee – chaired by Dr. Liu Datao, with Ms. Li Fan as a member.\nThe disclosure underscores Mabwell’s governance framework, highlighting a balanced mix of executive insight and independent oversight across its five specialized committees.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1149771039","isCrawlerRequest":true}